Beyond FDA Approval: Pure Global's Playbook for Navigating the Global Regulatory Maze with Your Continuous Glucose Monitoring (CGM) Device

The global market for Continuous Glucose Monitoring (CGM) devices is booming, offering incredible opportunities for MedTech innovators. However, the path to international success is littered with complex and varied regulatory hurdles. A device celebrated with FDA approval in the US can find itself grounded for years by the rigorous demands of the EU's MDR or China's NMPA. This episode of MedTech Global Insights dives deep into the real-world challenges of taking a CGM device global. We follow the journey of a MedTech company as they navigate the costly and time-consuming process of entering European and Asian markets, revealing the common pitfalls that can derail even the most promising innovations. We explore how a proactive, unified global strategy, powered by technology and local expertise, is the only way to win. A Real-World Scenario: Imagine your innovative, FDA-approved CGM device is ready to change lives in Europe. But you discover your clinical data is deemed insufficient by EU authorities, your chosen partner doesn’t have the right credentials, and you’re now facing a three-year delay and a budget overrun of millions. This is the reality for many, and this episode unpacks how to avoid it. In This Episode, We Unpack: 1. Why is the EU's MDR the "great filter" for so many MedTech devices coming from the US? 2. What are the specific, often-overlooked requirements of China's NMPA that can halt your market entry? 3. How can a single technical dossier be prepared to streamline submissions in over 30 countries simultaneously? 4. What is the true cost of a reactive, country-by-country regulatory strategy versus a unified global approach? 5. How can AI tools reduce your dossier preparation time from months to weeks? 6. What are the critical functions of a local, in-country representative that most companies get wrong? 7. How do you build a post-market surveillance plan that satisfies regulators in both Europe and North America? To learn more about navigating these challenges, contact us at [email protected] or visit https://pureglobal.com/.